Pfizer-BioNTech seeks federal authorization for its vaccine for children 6 months to 4 years old
Michael Bigham, MD, the chief quality officer at Akron Children's, discusses Pfizer's recent request for vaccine approval and provides and update on the impact of COVID in local children.